In 1960, the first paper on the pharmacology of imipramine, the 'original' antidepressive drug, was published in the British Journal of Pharmacology (Marshall et al. , 1960). It came from the Department of Clinical Research of the Crichton Royal Hospital, Dumfries, Scotland and not as might have been expected from a university department or the laboratories of a pharmaceutical firm. Under the circumstances, it seems relevant to record for the benefit of scientific historians, the somewhat tortuous chain of events that led to its publication.
Get full access to this article
View all access options for this article.
References
1.
Axelrod J., Whitby R., Hertting G. (1961) Effect of psychotrophic drugs on the uptake of [3H] noradrenaline by tissuesScience133: 383-384
2.
Axelrod J., Inscoe J.K. (1963) The uptake and binding of circulating serotonin and the effect of drugsJ Pharmacol Exp Ther141: 161-169
3.
Dick M., Todrick A. (1956) The excretion of 5-hydroxyindole-acetic acid (5-HIAA) by normal human subjects. Biochem J Proc Biochem Soc, Univers CollLondon March 1956
4.
Kuhn R. ( 1958) The treatment of depressive states with G22355 (imipramine HCl)Am J Psychiatr115: 459-464
5.
Marshall E.F., Tait A.C., Todrick A. (1958) The effect of reserpine on the blood sugar level in human subjectsBiochem J69
6.
Marshall E.F., Stirling G.S., Tait A.C., Todrick A. (1960) The effect of iproniazid and imipramine on the blood platelet 5-hydroxytryptamine level in manBr J Pharmacol15: 35-41
Pletscher A., Bernstein A. (1958) Increase of 5-hydroxytryptamine in blood platelets by isopropyl-isonicotinic acid hydrazideNature181: 1133
10.
Pryce I.J. (1958) Melancholia, glucose tolerance and body weightJ Mental Sci104: 421-427
11.
Todrick A., Dick M., Tait A.C. (1958) The effect of reserpine in therapeutic dosage on excretion of 5-hydroxyindole acetic acidBr Med J: 496-499
12.
Todrick A., Tait A.C., Marshall E.F. (1960) Blood platelet 5-hydroxytryptamine levels in psychiatric patientsJ Ment Sci106 : 884-890
13.
Todrick A., Marshall E.F., Tait A.C. (1960) Amine oxidase inhibition by drugs of the "Psychic Energiser" Group Proc 4th Int Congr Clin Chem
14.
Todrick A. (1962) Simplified methods of investigation of 5-hydroxyindole metabolismProc Assoc Clin Biochem2: 65
15.
Yates C.M., Todrick A., Tait A.C. (1963) Aspects of the clinical chemistry of desmethylimipramine in manJ Pharm Pharmacol15: 432-439
16.
Yates C.M., Todrick A., Tait A.C. (1964) Effect of imipramine and some analogues on the uptake of 5-hydroxytryptamine by human blood platelets in vitroJ Pharm Pharmacol16: 460-463
17.
Tait A.C. (1965) Discussion In Marks V, Pare M (eds), The scientific basis of drug therapy in psychiatry.Pergamon Press
18.
Moody J.P., Tait A.C., Todrick A. (1967) Plasma levels of imipramine and desmethylimipramine during therapyBr J Psychiatr113: 183-193
19.
Todrick A., Tait A.C. (1969) The inhibition of human platelet 5-hyroxytryptamine uptake by tricyclic antidepressive drugsJ Pharm Pharmacol21: 751-762
20.
Campbell I.C. , Todrick A. (1970) Plasma protein binding of tricyclic antidepressive drugsJ Pharm Pharmacol22: 226-227
21.
Todrick A. (1973) The laboratory assessment of the antidepressive action of chlorimipramine (anafranil)J Int Med Res1: 291
22.
Campbell I.C. , Todrick A. (1973) On the pharmacology and biochemistry of the amine-uptake mechanism in human blood plateletsBr J Pharmacol49: 279-287
23.
Todrick A., Tait A.C. (1974) Laboratory assessments of antidepressive activity: their value for clinical psychiatry and the understanding of depressionActivitas Nervosa Superiora16: 58-60
24.
Tait A.C., Todrick A. (1975) What are tricyclic antidepressant drugs?Br J Clin Pharmacol2: 93-94
25.
Campbell I.C. , Todrick A. (1976) The effects of 4-methyl ethyl tyramine, 4-dimethyl tyramine and tetra benazine on the release and uptake of 5-hydroxytryptamine by human blood platelets in vitroLife Sci18: 1091